Literature DB >> 18832169

Loss of Rb1 in the gastrointestinal tract of Apc1638N mice promotes tumors of the cecum and proximal colon.

Melanie H Kucherlapati1, Kan Yang, Kunhua Fan, Mari Kuraguchi, Dmitriy Sonkin, Andrew Rosulek, Martin Lipkin, Roderick T Bronson, Bruce J Aronow, Raju Kucherlapati.   

Abstract

To examine the role of Rb1 in gastrointestinal (GI) tumors, we generated mice with an Apc(1638N) allele, Rb(tm2brn) floxed alleles, and a villin-cre transgene (RBVCA). These animals had exon 19 deleted from Rb1 throughout the GI tract. We have shown previously that Rb1 deficiency is insufficient for GI tumor initiation, with inactivation of an Apc allele capable of overcoming the insufficiency. In this study we demonstrate that RBVCA mice have reduced median survival because of an increase in tumor incidence and multiplicity in the cecum and the proximal colon. Large intestinal tumors are predominantly adenomas, whereas the tumors of the small intestine are a mixture of adenomas and adenocarcinomas. We find truncation mutations to the second Apc allele in tumors of both the large and small intestine. Expression profiles of duodenal and cecal tumors relative to each other show unique gene subsets up and down regulated. Substantial expression patterns compare to human colorectal cancer, including recapitulation of embryonic genes. Our results indicate that Rb1 has significant influence over tumor location in the GI tract, and that both cecal and duodenal tumors initiate through inactivation of Apc. Expression profile analysis indicates the two tumor types differentially regulate distinct sets of genes that are over-expressed in a majority of human colorectal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832169      PMCID: PMC2563082          DOI: 10.1073/pnas.0802933105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  The related retinoblastoma (pRb) and p130 proteins cooperate to regulate homeostasis in the intestinal epithelium.

Authors:  Kevin Haigis; Julien Sage; Jon Glickman; Sarah Shafer; Tyler Jacks
Journal:  J Biol Chem       Date:  2005-10-28       Impact factor: 5.157

2.  RB family members as predictive and prognostic factors in human cancer.

Authors:  G Scambia; S Lovergine; V Masciullo
Journal:  Oncogene       Date:  2006-08-28       Impact factor: 9.867

3.  Promoter hypermethylation of the RB1 gene in glioblastomas.

Authors:  M Nakamura; Y Yonekawa; P Kleihues; H Ohgaki
Journal:  Lab Invest       Date:  2001-01       Impact factor: 5.662

4.  p21(WAF1/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo.

Authors:  W Yang; A Velcich; J Mariadason; C Nicholas; G Corner; M Houston; W Edelmann; R Kucherlapati; P R Holt; L H Augenlicht
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

5.  Xenopus embryonic E2F is required for the formation of ventral and posterior cell fates during early embryogenesis.

Authors:  A Suzuki; A Hemmati-Brivanlou
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

6.  Loss of pRb expression in pituitary adenomas is associated with methylation of the RB1 CpG island.

Authors:  D J Simpson; N A Hibberts; A M McNicol; R N Clayton; W E Farrell
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

7.  Cross-species comparison of human and mouse intestinal polyps reveals conserved mechanisms in adenomatous polyposis coli (APC)-driven tumorigenesis.

Authors:  Claudia Gaspar; Joana Cardoso; Patrick Franken; Lia Molenaar; Hans Morreau; Gabriela Möslein; Julian Sampson; Judith M Boer; Renée X de Menezes; Riccardo Fodde
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

8.  The APC tumor suppressor controls entry into S-phase through its ability to regulate the cyclin D/RB pathway.

Authors:  Christopher D Heinen; Kathleen Heppner Goss; James R Cornelius; George F Babcock; Erik S Knudsen; Timothy Kowalik; Joanna Groden
Journal:  Gastroenterology       Date:  2002-09       Impact factor: 22.682

9.  Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer.

Authors:  Sergio Kaiser; Young-Kyu Park; Jeffrey L Franklin; Richard B Halberg; Ming Yu; Walter J Jessen; Johannes Freudenberg; Xiaodi Chen; Kevin Haigis; Anil G Jegga; Sue Kong; Bhuvaneswari Sakthivel; Huan Xu; Timothy Reichling; Mohammad Azhar; Gregory P Boivin; Reade B Roberts; Anika C Bissahoyo; Fausto Gonzales; Greg C Bloom; Steven Eschrich; Scott L Carter; Jeremy E Aronow; John Kleimeyer; Michael Kleimeyer; Vivek Ramaswamy; Stephen H Settle; Braden Boone; Shawn Levy; Jonathan M Graff; Thomas Doetschman; Joanna Groden; William F Dove; David W Threadgill; Timothy J Yeatman; Robert J Coffey; Bruce J Aronow
Journal:  Genome Biol       Date:  2007       Impact factor: 13.583

10.  Novel roles for MLH3 deficiency and TLE6-like amplification in DNA mismatch repair-deficient gastrointestinal tumorigenesis and progression.

Authors:  Peng-Chieh Chen; Mari Kuraguchi; John Velasquez; Yuxun Wang; Kan Yang; Robert Edwards; Dan Gillen; Winfried Edelmann; Raju Kucherlapati; Steven M Lipkin
Journal:  PLoS Genet       Date:  2008-06-13       Impact factor: 5.917

View more
  11 in total

1.  Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectum.

Authors:  Mai Yamauchi; Teppei Morikawa; Aya Kuchiba; Yu Imamura; Zhi Rong Qian; Reiko Nishihara; Xiaoyun Liao; Levi Waldron; Yujin Hoshida; Curtis Huttenhower; Andrew T Chan; Edward Giovannucci; Charles Fuchs; Shuji Ogino
Journal:  Gut       Date:  2012-03-17       Impact factor: 23.059

2.  A prognostic analysis of 895 cases of stage III colon cancer in different colon subsites.

Authors:  Yan Zhang; Junli Ma; Sai Zhang; Ganlu Deng; Xiaoling Wu; Jingxuan He; Haiping Pei; Hong Shen; Shan Zeng
Journal:  Int J Colorectal Dis       Date:  2015-06-09       Impact factor: 2.571

Review 3.  RB1, development, and cancer.

Authors:  Meenalakshmi Chinnam; David W Goodrich
Journal:  Curr Top Dev Biol       Date:  2011       Impact factor: 4.897

4.  Retinoblastoma protein (pRb), but not p107 or p130, is required for maintenance of enterocyte quiescence and differentiation in small intestine.

Authors:  Jun Guo; Shannon Longshore; Rajalakshmi Nair; Brad W Warner
Journal:  J Biol Chem       Date:  2008-11-03       Impact factor: 5.157

5.  An Msh2 conditional knockout mouse for studying intestinal cancer and testing anticancer agents.

Authors:  Melanie H Kucherlapati; Kyeryoung Lee; Andrew A Nguyen; Alan B Clark; Harry Hou; Andrew Rosulek; Hua Li; Kan Yang; Kunhua Fan; Martin Lipkin; Roderick T Bronson; Linda Jelicks; Thomas A Kunkel; Raju Kucherlapati; Winfried Edelmann
Journal:  Gastroenterology       Date:  2009-11-18       Impact factor: 22.682

Review 6.  Strategies to achieve conditional gene mutation in mice.

Authors:  Jessica J Gierut; Tyler E Jacks; Kevin M Haigis
Journal:  Cold Spring Harb Protoc       Date:  2014-04-01

7.  Insertional mutagenesis identifies multiple networks of cooperating genes driving intestinal tumorigenesis.

Authors:  H Nikki March; Alistair G Rust; Nicholas A Wright; Jelle ten Hoeve; Jeroen de Ridder; Matthew Eldridge; Louise van der Weyden; Anton Berns; Jules Gadiot; Anthony Uren; Richard Kemp; Mark J Arends; Lodewyk F A Wessels; Douglas J Winton; David J Adams
Journal:  Nat Genet       Date:  2011-11-06       Impact factor: 38.330

8.  Inactivation of the retinoblastoma gene yields a mouse model of malignant colorectal cancer.

Authors:  T Parisi; R T Bronson; J A Lees
Journal:  Oncogene       Date:  2015-03-09       Impact factor: 9.867

9.  A role for the vitamin D pathway in non-intestinal lesions in genetic and carcinogen models of colorectal cancer and in familial adenomatous polyposis.

Authors:  Yong-Sik Bong; Shahin Assefnia; Therese Tuohy; Deborah W Neklason; Randall W Burt; Jaeil Ahn; Paul J Bueno De Mesquita; Stephen W Byers
Journal:  Oncotarget       Date:  2016-12-06

10.  Correlation between expression levels of lncRNA FER1L4 and RB1 in patients with colorectal cancer.

Authors:  Marjan Ostovarpour; Mohammad Khalaj-Kondori; Tayyebeh Ghasemi
Journal:  Mol Biol Rep       Date:  2021-06-16       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.